Análises clínicas
Servicio
Publicacións nas que colabora con Felipe Casanueva Freijo (17)
2016
-
Impact of mean cell hemoglobin on Hb A1c-defined glycemia status
Clinical Chemistry, Vol. 62, Núm. 12, pp. 1570-1578
-
Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome
Endocrine, Vol. 54, Núm. 2, pp. 411-421
2015
-
High Incidence of Hypoglycemia in Stable Insulin-Treated Type 2 Diabetes Mellitus: Continuous Glucose Monitoring vs. Self-Monitored Blood Glucose. Observational Prospective Study
Canadian Journal of Diabetes, Vol. 39, Núm. 5, pp. 428-433
-
Influence of the exon 3 deletion of GH receptor and IGF-I level at diagnosis on the efficacy and safety of treatment with somatotropin in adults with GH deficiency
Pituitary, Vol. 18, Núm. 1, pp. 101-107
-
Influence of the glycation gap on the diagnosis of type 2 diabetes
Acta Diabetologica, Vol. 52, Núm. 3, pp. 453-459
2012
-
Estimation of the glycation gap in diabetic patients with stable glycemic control
Diabetes Care, Vol. 35, Núm. 12, pp. 2447-2450
-
Intrapersonal HbA1c variability and the risk of progression of nephropathy in patients with Type2 diabetes
Diabetic Medicine, Vol. 29, Núm. 12, pp. 1562-1566
2011
-
Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: Prevalence, evolution of hormone dysfunction and genetic analysis
Neuroendocrinology, Vol. 93, Núm. 3, pp. 181-188
-
Progression of nephropathy in type 2 diabetes: The glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c)
Clinical Chemistry, Vol. 57, Núm. 2, pp. 264-271
2010
-
Pegvisomant-induced liver injury is related to the UGT1A1*28 polymorphism of Gilbert's syndrome
Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 5, pp. 2147-2154
-
The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly
Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 1, pp. 222-229
2005
-
Genetic basis of short stature
Journal of Endocrinological Investigation
2004
-
Therapeutic optimization of growth hormone deficiency in children and adolescents
Journal of Pediatric Endocrinology and Metabolism, Vol. 17, Núm. SUPPL. 3, pp. 401-410
2003
-
Optimización terapéutica del déficit de hormona de crecimiento en niños y adolescentes
Anales de Pediatria, Vol. 58, Núm. SUPPL. 2, pp. 3-11
2002
-
Presence of bovine leptin in edible commercial milk and infant formula
Journal of Endocrinological Investigation, Vol. 25, Núm. 8, pp. 670-674
2000
-
Ghrelin-induced growth hormone secretion in humans
European Journal of Endocrinology, Vol. 143, Núm. 6
1998
-
Acute changes in free-fatty acids (FFA) do not alter serum leptin levels
Journal of Endocrinological Investigation, Vol. 21, Núm. 8, pp. 526-530